Cargando…

Prognostic Power of Pathogen Cell-Free DNA in Staphylococcus aureus Bacteremia

BACKGROUND: Staphylococcus aureus is a leading global cause of bacteremia that can cause invasive tissue infections with high morbidity and mortality despite appropriate antibiotic therapy. Clinicians lack sufficient tools to rapidly identify patients with a poor prognosis to guide diagnostic workup...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guimaraes, Alessander O, Gutierrez, Johnny, Maskarinec, Stacey A, Cao, Yi, Hong, Kyu, Ruffin, Felicia, Carrasco-Triguero, Montserrat, Peck, Melicent C, Fowler, Vance G, Baruch, Amos, Rosenberger, Carrie M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483138/ https://www.ncbi.nlm.nih.gov/pubmed/31041341 http://dx.doi.org/10.1093/ofid/ofz126

Ejemplares similares

Risk stratification biomarkers for Staphylococcus aureus bacteraemia
por: Cao, Yi, et al.
Publicado: (2020)

1058. Prognostic Biomarkers for Persistent Bacteremia and Mortality in Complicated S. aureus Bloodstream Infection
por: Cao, Yi, et al.
Publicado: (2018)

Sustained Circulating Bacterial Deoxyribonucleic Acid Is Associated With Complicated Staphylococcus aureus Bacteremia
por: Gutierrez, Johnny, et al.
Publicado: (2019)

Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care
por: Westgeest, Annette C, et al.
Publicado: (2023)

216. Bacterial Genotype and Clinical Outcomes in Solid Organ Transplant Recipients with Staphylococcus aureus Bacteremia
por: Eichenberger, Emily, et al.
Publicado: (2021)

167. A Phase 1b, Randomized, Double-blind, Placebo-controlled, Multiple-ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Patients with staphylococcus Aureus Bacteremia Receiving Standard-of-care Antibiotics
por: Lim, Jeremy, et al.
Publicado: (2020)

The Risk of Cardiac Device-Related Infection in Bacteremic Patients Is Species Specific: Results of a 12-Year Prospective Cohort
por: Maskarinec, Stacey A, et al.
Publicado: (2017)

1039. Surveillance Blood Cultures Associated With Decreased Mortality in Gram-Negative Bacteremia
por: Maskarinec, Stacey A, et al.
Publicado: (2018)

1060. Risk Factors for Recurrent Staphylococcus aureus Bacteremia
por: Choi, Seong-Ho, et al.
Publicado: (2018)

181. Demographic and Geographic Epidemiology of Staphylococcus aureus Bacteremia using Geographic Information Systems Mapping and Spatial Statistics
por: Marshall, Julia, et al.
Publicado: (2021)

189. Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients with staphylococcus Aureus Bacteremia: Results from a 20-year Prospective Cohort
por: Dagher, Michael M, et al.
Publicado: (2020)

1305. Comparison of Pharmacokinetics of DSTA4637S, a novel THIOMAB(TM) Antibody-Antibiotic Conjugate, in Patients with Staphylococcus aureus Bacteremia Receiving Standard-of-Care Antibiotics with Pharmacokinetics in Healthy Volunteers
por: Rymut, Sharon M, et al.
Publicado: (2020)

1030. Association of Female Sex with Mortality in Patients with Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis
por: Westgeest, Annette C, et al.
Publicado: (2023)

Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus in mice
por: Zhou, Chenguang, et al.
Publicado: (2016)

1373. Racial Disparities in Clinical Characteristics and Outcomes for Methicillin Susceptible and Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Mohnasky, Michael C, et al.
Publicado: (2021)

Complicated Staphylococcus aureus Bacteremia (SAB) Is Associated with Genetic Variation in GLS2
por: Fowler, Vance, et al.
Publicado: (2017)

307. Exploring HLA genotypes as contributing risk factors in Staphylococcus aureus bacteremia
por: Tao, Yazhong, et al.
Publicado: (2023)

637. Whole-Genome Sequencing (WGS) of Isolates from Resolving (RB) and Persistent (PB) Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Sharma-Kuinkel, Batu K, et al.
Publicado: (2019)

Benefit of Echocardiography in Patients With Staphylococcus aureus Bacteremia at Low Risk of Endocarditis
por: Heriot, George S, et al.
Publicado: (2018)

Maternal Bacteremia Caused by Staphylococcus Aureus With a Focus on Infective Endocarditis
por: Morelli, Morgan K, et al.
Publicado: (2020)

Evaluating genetic susceptibility to Staphylococcus aureus bacteremia in African Americans using admixture mapping
por: Cyr, D D, et al.
Publicado: (2017)

Staphylococcus aureus Bacteremia in Patients Infected With COVID-19: A Case Series
por: Cusumano, Jaclyn A, et al.
Publicado: (2020)

The Effect of Insurance on Appropriate Hospital Discharge Antibiotics for Patients With Staphylococcus aureus Bacteremia
por: McHale, Thomas, et al.
Publicado: (2020)

Staphylococcus aureus Bacteremia in Pediatric Patients: Uncovering a Rural Health Challenge
por: Whittington, Kyle J, et al.
Publicado: (2023)

Patients’ Experiences With Staphylococcus aureus and Gram-Negative Bacterial Bloodstream Infections: Results From Cognitive Interviews to Inform Assessment of Health-Related Quality of Life
por: King, Heather A, et al.
Publicado: (2021)

The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Miller, William R, et al.
Publicado: (2018)

960. Clinical impact of follow-up blood cultures in gram-negative bloodstream infections: A validation cohort
por: Thaden, Joshua T, et al.
Publicado: (2023)

Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia
por: van der Vaart, Thomas W, et al.
Publicado: (2021)

Intermittent Negative Blood Cultures in Staphylococcus aureus Bacteremia; a Retrospective Study of 1071 Episodes
por: Stewart, James D, et al.
Publicado: (2019)

The Cost-effectiveness of Cefazolin Compared With Antistaphylococcal Penicillins for the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia
por: Pliakos, Elina Eleftheria, et al.
Publicado: (2021)

The Impact of Aging and Toll-like Receptor 2 Deficiency on the Clinical Outcomes of Staphylococcus aureus Bacteremia
por: Hu, Zhicheng, et al.
Publicado: (2023)

Staphylococcus aureus Infections After Elective Cardiothoracic Surgery: Observations From an International Randomized Placebo-Controlled Trial of an Investigational S aureus Vaccine
por: Allen, Keith B., et al.
Publicado: (2014)

Increased Age-Dependent Risk of Death Associated With lukF-PV-Positive Staphylococcus aureus Bacteremia
por: Knudsen, Trine A., et al.
Publicado: (2016)

Association of Infectious Disease Consultation With Clinical Outcomes in Patients With Staphylococcus aureus Bacteremia at Low Risk for Endocarditis
por: Yousaf, Anna, et al.
Publicado: (2018)

Risk Factors and Outcomes Associated With Hospital-Onset Peripheral Intravenous Catheter–Associated Staphylococcus aureus Bacteremia
por: Blauw, Mica, et al.
Publicado: (2019)

All-Cause and Infection-Related Mortality in Staphylococcus aureus Bacteremia, a Multicenter Prospective Cohort Study
por: van der Vaart, Thomas W, et al.
Publicado: (2022)

A genome-wide association study of variants associated with acquisition of Staphylococcus aureus bacteremia in a healthcare setting
por: Nelson, Charlotte L, et al.
Publicado: (2014)

Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Host, Pathogen, and Treatment
por: Parsons, Joshua B., et al.
Publicado: (2023)

Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy
por: Wilson Dib, Rita, et al.
Publicado: (2018)

Formal Infectious Diseases Specialist Consultation Improves Long-term Outcome of Methicillin-Sensitive Staphylococcus aureus Bacteremia
por: Forsblom, Erik, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lqs9vs7dboaejvvobnlhotbdg7